Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer
Authors
Keywords
Cancer chemotherapy, Breast cancer, Platelets, Lymph nodes, Biomarkers, Cancer treatment, Histology, Inflammation
Journal
PLoS One
Volume 13, Issue 11, Pages e0207224
Publisher
Public Library of Science (PLoS)
Online
2018-11-15
DOI
10.1371/journal.pone.0207224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2016) Xiaoxian (Bill) Li et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
- (2016) Yoon Yang Jung et al. Journal of Breast Cancer
- Platelet–Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer
- (2016) Yuka Asano et al. PLoS One
- Utility of Peripheral Blood Parameters in Predicting Breast Cancer Risk
- (2015) Yildiz Okuturlar et al. Asian Pacific Journal of Cancer Prevention
- Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer
- (2015) C-H Koh et al. BRITISH JOURNAL OF CANCER
- Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis
- (2015) X. Yu et al. Clinical & Translational Oncology
- Tumor-Infiltrating Lymphocytes and Response to Platinum in Triple-Negative Breast Cancer
- (2015) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
- (2015) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab
- (2015) Roberto Salgado et al. JAMA Oncology
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
- (2014) S Krenn-Pilko et al. BRITISH JOURNAL OF CANCER
- Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) A. J. Templeton et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Characterization and clinical impact of residual disease after neoadjuvant chemotherapy
- (2013) Giuseppe Viale BREAST
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
- (2012) Laura J. Esserman et al. JOURNAL OF CLINICAL ONCOLOGY
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
- (2011) Basem Azab et al. ANNALS OF SURGICAL ONCOLOGY
- Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer
- (2011) Manfred Kaufmann et al. ANNALS OF SURGICAL ONCOLOGY
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs
- (2011) Laura J. Esserman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma
- (2010) Yoshio Ohno et al. JOURNAL OF UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search